Back Bay Life Science Advisors
Market Insights
Investment Banking Analytics Strategic Advisory
Company Global Partnerships Meet Our Team Careers Resource Library Locations
DNB//Back Bay Partnership DNB//Back Bay Healthcare Team
Corporate Contact Toronto Office
OUR SERVICES Investment Banking Analytics Strategic Advisory About Company Global Partnerships Meet Our Team Careers Resource Library Locations Market Insights DNB//BACK BAY DNB//Back Bay Partnership DNB//Back Bay Healthcare Team Contact Corporate Contact Toronto Office
Back Bay Life Science Advisors

Boston Business Journal: Gene Therapy Regulation

Back Bay Senior Vice President Steve Gauldie spoke with the Boston Business Journal about new drug regulation:. Read the article at The Boston Business Journal: Gene therapies to test FDA's approach to regulating drugs after launch, experts say.

News, Life Science Media, Back Bay in the NewsStephen Gauldie, PhDAugust 22, 2019Drug Regulation
Facebook0 Twitter LinkedIn0 Reddit Tumblr 0 Likes
Previous

Back Bay to Sponsor the Nordic Life Science Days, Sweden

EventsJocelyn MillerAugust 22, 2019
Next

Back Bay To Sponsor Biotech Week Boston

Events, Industry ConferencesBack Bay Life Science AdvisorsAugust 6, 2019
 

545 Boylston Street
12th Floor
Boston, MA 02116

+1 617.236.0954 Office
+1 617.236.1215 Fax

Boston | Toronto

 

OUR SERVICES


STRATEGIC ADVISORY >>

  • Life sciences corporate growth and market access strategy

  • Franchise, business unit & therapeutic area strategy

  • Competitive intelligence

  • Asset & development prioritization

  • Platform implementation

  • Payor/Pricing strategy

  • Contracting strategy

  • Launch & counter-launch strategy

  • Product positioning, branding & messaging

  • Life-cycle management

  • Corporate growth strategy

  • Liquidity & exit planning

INVESTMENT BANKING >>

FINANCING >>

  • Mergers, acquisitions & divestitures

  • IPO preparedness and execution

  • Private & public company, cross-border execution

  • Financing support

  • Fairness opinion, valuation

  • Treasury solutions

  • Fixed income origination

  • Equity capital markets

  • Liquidity and exit planning

  • Due diligence and valuation

  • Divestments

  • Licensing (buy and sell side)

  • Partnering

  • Recapitalization

  • New Company formation

  • Investment Grade Bonds

  • High yield and convertible bonds

  • Debt and restructuring

Subscribe

Sign up with your email address to receive weekly market updates.

We respect your privacy.

Thank you for subscribing.


©2025 Back Bay Life Science Advisors | Privacy Policy